Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vigabatrin in post-anoxic status epilepticus
NCT04772547Phase 2Completed
- Sponsor
- University of Florida
- Start
- Sep 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vigabatrin in status epilepticus (SE), sponsored by University of Florida. Started Sep 2021; status: completed.
02
Drugs
vigabatrin
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT04772547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04772547.